Drugs for Neglected Diseases Initiative
The Drugs for Neglected Diseases initiative is a collaborative, patients' needs-driven, non-profit drug research and development organization that is developing new treatments for neglected diseases, notably leishmaniasis, sleeping sickness, Chagas disease, malaria, filarial diseases, mycetoma, paediatric HIV, cryptococcal meningitis, hepatitis C, and dengue. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Drugs for Neglected Diseases Initiative, Switzerland, covering academic research published from 2003 to 2024. Read More.
Open Access Percentage
83%
Total
Publications
762
Total Open
Publications
635
Total
Citations
33K
Open Access
Percentage
83%
Total
Publications
762
Total Open
Publications
635
Total
Citations
33K
Breakdown
Publisher Open
10%
Both
62%
Other Platform Open
11%
Closed
17%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 59%
325
Hybrid 31%
172
No Guarantees 10%
54
Other Platform Open
Domain 81%
454
Institution 44%
249
Other Internet 14%
80
Public 12%
67
Preprint 10%
57
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 452 |
Europe PMC | Domain | 219 |
Semantic Scholar | Public | 57 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 41 |
lshtm.ac.uk OAI-PMH Repository | Institution | 38 |
University College London - UCL Discovery | Institution | 37 |
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia | Other Internet | 33 |
DOI | Other Internet | 33 |
St George's University of London - St George's Online Research Archive | Institution | 30 |
London School of Hygiene and Tropical Medicine - LSHTM Research Online | Institution | 26 |